BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2300
-0.0100 (-4.17%)
At close: 2:24PM EST
Stock chart is not supported by your current browser
Previous Close0.2400
Open0.2320
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.2300 - 0.2320
52 Week Range0.2000 - 0.4600
Volume10,380
Avg. Volume67,411
Market Cap30.427M
Beta (3Y Monthly)-0.20
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1997-05-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE18 days ago

    BioLargo's Advanced Oxidation System (AOS) Test Data Shows Breakthrough to Treat and Reduce the Toxicity of Micropollutants Associated with Municipal Wastewater

    WESTMINSTER, CA / ACCESSWIRE / November 21, 2018 / BioLargo, Inc. (OTCQB: BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today announced ...

  • ACCESSWIRE20 days ago

    BioLargo Tops $1M in Annual Revenues for First Time

    WESTMINSTER, CA / ACCESSWIRE / November 19, 2018 / BioLargo, Inc. (BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today announced that it had passed an important milestone - $1,000,000 in annual revenues (year-to-date in 2018). BioLargo president Dennis P. Calvert commented, "Sales of our odor control products have doubled each of the last four years. Odor-No-More, Inc. President Joseph Provenzano commented on the milestone, "We are repeatedly told by our customers we have the best odor-control product in the market.

  • ACCESSWIRE24 days ago

    BioLargo Reports Record Results

    WESTMINSTER, CA / ACCESSWIRE / November 15, 2018 / BioLargo, Inc. (OTCQB: BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today announced ...

  • GlobeNewswirelast month

    BioLargo, Inc.’s CEO Discusses Business Milestones and FDA Progress with Uptick Newswire’s Stock Day Podcast

    Dennis Calvert, CEO of BioLargo, Inc. (OTCQB:BLGO), recently spoke with Stock Day Podcast’s Everett Jolly to update listeners on the company’s recent milestones. Jolly started out the interview highlighting that BioLargo’s odor and VOC control products are set to do over $1 million in revenue in 2018. “We launched the product about two years ago into the municipal waste handling industry,” Calvert explains to Uptick.

  • GlobeNewswirelast month

    BioLargo Letter to Stockholders Details Company’s Recent Milestones and Successes

    WESTMINSTER, Calif., Oct. 31, 2018 -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today.

  • GlobeNewswire2 months ago

    BioLargo Closes Bridge Financing with TRITON FUNDS LP, the Largest Student-Run Investment Fund in the Nation

    WESTMINSTER, Calif., Oct. 22, 2018 -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today.

  • GlobeNewswire2 months ago

    BioLargo acquires breakthrough stem cell therapy technology to expand medical product portfolio

    BioLargo, Inc. (BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, announced today that it had entered into definitive agreements to acquire a breakthrough stem cell therapy technology called “SkinDisc.” Developed by Scion Solutions, LLC, SkinDisc uses a patient’s own bone marrow and plasma to generate a cell-rich biogel which heals chronic wounds. The SkinDisc product will be sold through BioLargo subsidiary Clyra Medical Technologies, Inc. In addition to the SkinDisc product, Scion’s key team members will join Clyra to support Clyra’s commercial strategy, including Dr. Brock Liden, a renowned medical podiatrist and expert in wound care and diabetic limb salvage, and Spencer Brown, a medical device industry veteran with more than 35 years of experience working in medical sales, account management, and distribution in the medical device industry.

  • GlobeNewswire2 months ago

    BioLargo CEO Dennis Calvert Reports Breakthrough Commercial Success

    WESTMINSTER, Calif., Sept. 25, 2018 -- BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company,.

  • ACCESSWIRE6 months ago

    BioLargo, Inc. to Present at the 8th Annual LD Micro Invitational

    LOS ANGELES, CA / ACCESSWIRE / June 1, 2018 / BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company today announced that it ...

  • ACCESSWIRE8 months ago

    BioLargo, Inc. to Present at the Planet MicroCap Showcase 2018 on April 25 in Las Vegas, NV

    WESTMINSTER, CA / ACCESSWIRE / April 20, 2018 / BioLargo, Inc., (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, will present at the ...

  • ACCESSWIRE9 months ago

    BioLargo, Inc. to Present at the Inaugural LD Micro Virtual Conference

    LOS ANGELES, CA / ACCESSWIRE / March 7, 2018 / BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, today announced that ...